questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 February 2026 to Question 110592, whether his Department has made an estimate of the earliest date nerandomilist could become available to patients after NICE publishes
answerText: Subject to licensing, the National Institute for Health and Care Excellence (NICE) currently expects to publish final guidance on nerandomilast in September 2026. In formulating its recommendations, NICE's independent Appraisal Committee expects to hold i...
heading: Idiopathic Pulmonary Fibrosis: Drugs